Interim Condensed Consolidated Statements of Cash Flows (Current Period Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash Flows From Operating Activities:
Net income	$ 25,740	$ 28,147
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	16,505	13,928
Provision for doubtful accounts receivable	3,121	1,522
Equity in earnings of unconsolidated investments	(3,654)	(7,595)
Distributions from unconsolidated investments	9,251	9,979
Gains on sale of restricted marketable securities	(172)	(384)
Deferred income taxes	(4,085)	(2,368)
Stock–based compensation	1,170	1,359
Changes in operating assets and liabilities, net of the effect of acquisitions:
Restricted cash and cash equivalents	(1,622)	(5,602)
Accounts receivable	(4,107)	(1,356)
Income tax receivable	(2,829)	5,933
Inventories	(33)	311
Prepaid expenses	(1,445)	(1,265)
Other Assets	507	282
Trade accounts payable	3,887	696
Accrued payroll	(20,091)	1,956
Amounts due to third party payors	1,289	1,487
Other current liabilities and accrued risk reserves	807	(2,588)
Other noncurrent liabilities	1,226	1,154
Deferred revenue	1,530	1,483
Net cash provided by operating activities	26,995	47,079
Cash Flows From Investing Activities:
Additions to property and equipment	(22,963)	(20,096)
Investments in unconsolidated limited liability companies	(1,312)
Acquisition of non-controlling interest	(768)
Investments in notes receivable	(767)
Collections of notes receivable	2,937	578
Change in restricted cash and cash equivalents	364	2,640
Purchase of restricted marketable securities	(30,173)	(42,881)
Sale of restricted marketable securities	27,641	38,150
Net cash used in investing activities	(25,041)	(21,609)
Cash Flows From Financing Activities:
Tax benefit (expense) from stock–based compensation	201	(225)
Principal payments under capital lease obligations	(960)
Dividends paid to preferred stockholders	(4,335)	(4,336)
Dividends paid to common stockholders	(9,078)	(8,475)
Issuance of common shares	6,752	270
Repurchase of common shares		(4,700)
Entrance fee deposits	(42)	(40)
Change in deposits	(439)	(31)
Net cash used in financing activities	(7,901)	(17,537)
Net (Decrease) Increase in Cash and Cash Equivalents	(5,947)	7,933
Cash and Cash Equivalents, Beginning of Period	81,705	66,701
Cash and Cash Equivalents, End of Period	75,758	74,634
Supplemental disclosure of non-cash investing and financing activities:
Buildings, personal property, and obligations recorded under capital lease agreements	$ 39,032